$10,000 in NuScale at Its 52-Week High Is Worth About $1,650 Today
NuScale Power (NYSE: SMR) shares have fallen sharply since a 52-week high of $57.42 in October, trading near $9.50 and cutting a $10,000 investment to about $1,650. Q2 revenue was $75,000 versus $8.1M a year earlier. NuScale filed to sell up to $750M more stock; TVAs PPA talks and Romania’s RoPower project remain pending.
How this was made
The 30-second read
Why it matters
The text frames a deteriorating near-term revenue picture (Q2 revenue $75,000 vs $8.1M prior year) alongside a new $750M stock-sale filing, while key order catalysts remain non-binding.
Market read
For SMR, the actionable update is the new equity-raising authorization plus evidence of revenue collapse, shifting the market’s focus to contract conversion probability.
What to watch
The article emphasizes pending orders, but traders may also watch for incremental milestones tied to TVA negotiations and Romania’s shareholder-vote conditions, which could reprice the probability of contract conversion faster than revenue recognition.
Background
NuScale is an SMR developer whose valuation has historically depended on regulatory design approval and the ability to secure large offtake contracts.
Ticker impact
NuScale filed to sell up to $750 million more stock, while Q2 revenue fell to $75,000 and orders remain pending.
Near-term bias likely remains bearish until a power purchase agreement or other binding order is announced; volatility should stay elevated around financing and shareholder-vote milestones.
The article’s newest concrete items are the $750 million shelf/secondary filing, the sharp revenue decline, and the lack of signed replacement work, all of which weaken the near-term fundamentals. It also notes cash coverage and that commercialization/order catalysts are still pending, which can cap downside but delays a fundamental re-rating.
Market effects
Highlights financing and contracting risk for US small modular reactor developers, where valuation depends on converting discussions into binding offtake agreements.
US utility commercialization timelines (TVA) remain a gating factor for SMR-related sentiment.
Romania project progress is still contingent on conditions including a shareholder vote, underscoring execution risk for international SMR deployments.
Counterpoint
The cash and investments ($1.9B) reduce immediate survival risk, and the design approval plus large partner supply chain could accelerate future contracting once offtake negotiations clear.
Key entities
- companyNuScale Power
SMR developer facing dilution risk and stalled revenue, with commercialization discussions still pending.
- counterpartyTennessee Valley Authority
In discussions with NuScale’s commercialization partner toward a potential power purchase agreement.
- projectRomania RoPower project
Six-module project still working through conditions attached to a shareholder vote.
